Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study. [electronic resource]
Producer: 19991222Description: 1175-9 p. digitalISSN:- 0923-7534
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Agents -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Female
- Glutamates -- administration & dosage
- Guanine -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Palliative Care
- Pemetrexed
- Survival Analysis
- Thymidylate Synthase -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.